This IMA test was developed to measure the amount of ischemia-modified albumin (IMA) in the blood. However, the test was never widely used and is no longer available for clinical use in the U.S. IMA was thought to be a promising cardiac biomarker, and a version of the test was approved by the FDA to help rule out cardiac ischemia in people with chest pain whose diagnosis was not clear. It was always ordered along with or following a troponin test and an ECG to provide the doctor added information if the initial troponin test was negative and the ECG was not definitive. Though this test is no longer available for use in patient care, some scientists continue to study IMA in research settings.
© 2017 American Association for Clinical Chemistry, republished from Lab Tests Online.*
Descriptions of clinical laboratory tests were originally prepared for use on Lab Tests Online, an award-winning patient education website on clinical laboratory testing. Lab Tests Online is produced by the American Association for Clinical Chemistry (AACC), a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. The Lab Tests Online website is developed in collaboration with other laboratory professional societies and is funded in part through corporate sponsorships.